GPM6B and neoplasm: Previous studies have reported that GPM6B regulates 5-hydroxytryptamine (5-HT) uptake and reduces 5-HT absorption in prostate cancer cells, thereby inhibiting tumor cell proliferation (Fjorback et al., 2009; He et al., 2020).